Dr. Kennedy Chibesa is currently serving as the Molecular Biology Supervisor at the Centre for Infectious Disease Research in Zambia (CIDRZ) Central Laboratory in Lusaka, Zambia. He is also an Affiliate Laboratory Member of the University of the Free State Next Generation Sequencing (UFS-NGS) Unit, where his research interests align with the unit’s focus on viral genomics and systems biology. Dr. Chibesa was a European and Developing Countries Clinical Trials Partnership (EDCTP) 2 PhD Fellow at CIDRZ and completed his PhD in Medical Virology under the supervision of Prof. Martin Munene Nyaga at the University of the Free State. His doctoral work, titled Effects of the Gut Microbiome and Environmental Enteric Dysfunction on Immune Responses to the oral inactivated Enterotoxigenic E. coli ETVAX® Vaccine: An Exploratory Study in Zambian Children, contributes to the growing body of knowledge on oral vaccine performance in low- and middle-income countries. Through a multi-omics approach, his research explores how gut microbial composition, viral burden, iron status, and gut barrier integrity influence vaccine immunogenicity, offering insights into the persistent challenge of suboptimal oral vaccine responses in vulnerable child populations. Dr. Chibesa is an emerging researcher in the field of enteric viruses and continues to build his career as an independent scientist. His work reflects a commitment to advancing global health through integrative research and operational excellence in laboratory science.
